The Twentieth World Health Assembly, Considering the constant and rapid increase in the number of pharmaceutical preparations available on the market; Noting that in certain cases drugs have been advertised without having undergone the necessary experimental and clinical evaluation; and Considering the desirability of internationally acceptable criteria for the advertising of pharmaceutical products, REQUESTS the Director-General to study the ethical and scientific criteria that, from the medical point of view, should govern the advertising of drugs, and to report thereon to the forty-first session of the Executive Board and to the Twenty-first World Health Assembly. Handb. Res., 8th ed., 1.3.3 Eleventh plenary meeting, 23 May 1967 (Committee on Programme and Budget, sixth report)